Clinical trial
A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in…
NCT00246259 · Janssen-Ortho Inc., Canada, Industry · Completed
Key facts
| NCT number | NCT00246259 |
|---|---|
| Title | A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis |
| Official title | An Open-Label Randomized Trial Comparing Risperdal Consta With Oral Antipsychotic Care in the Treatment of Early Psychosis |
| Lead sponsor | Janssen-Ortho Inc., Canada, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychotic Disorders |
| Intervention type | Drug |
| Interventions | Risperidone long-acting injection (LAI), Oral Antipsychotic |
| Enrollment | 77 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Oct 31, 2005 |
| Last update posted | Dec 11, 2013 |
| Countries | Canada |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: